← FDA Drug Approvals (Drugs@FDA)
FOSAPREPITANT DIMEGLUMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2019-09-05
Drug application
- FDA Application #
ANDA204015- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FOSAPREPITANT DIMEGLUMINE
- Generic name
- FOSAPREPITANT
- Active ingredients
- FOSAPREPITANT DIMEGLUMINE
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- MYLAN LABS LTD
- Manufacturer
- Mylan Institutional LLC
- First approval
- 2019-09-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown